BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28608242)

  • 1. F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.
    Subhawong TK; Winn A; Shemesh SS; Pretell-Mazzini J
    Skeletal Radiol; 2017 Sep; 46(9):1233-1239. PubMed ID: 28608242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroid Tumors as Incidental Findings and Differential Diagnosis between Enchondromas and Low-grade Chondrosarcomas.
    Afonso PD; Isaac A; Villagrán JM
    Semin Musculoskelet Radiol; 2019 Feb; 23(1):3-18. PubMed ID: 30699449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of
    Zhang Q; Xi Y; Li D; Yuan Z; Dong J
    J Orthop Surg Res; 2020 Jun; 15(1):229. PubMed ID: 32571371
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Annovazzi A; Anelli V; Zoccali C; Rumi N; Persichetti A; Novello M; Sciuto R; Bertoni F; Ferraresi V; Biagini R
    Ann Nucl Med; 2019 Nov; 33(11):813-821. PubMed ID: 31396797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma.
    Choi WH; Han EJ; Chang KB; Joo MW
    Sci Rep; 2020 Jun; 10(1):10587. PubMed ID: 32601314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can 18F-FDG PET/CT diagnose malignant change in benign chondroid tumors?
    Purandare NC; Puranik A; Shah S; Agrawal A; Puri A; Gulia A; Nayak P; Rekhi B; Rangarajan V
    Nucl Med Commun; 2019 Jun; 40(6):645-651. PubMed ID: 30921251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
    Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
    J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondromyxoid fibroma of the rib mimics a chondrosarcoma on 18F-FDG PET/CT.
    Makis W; Ciarallo A; Lisbona R
    Acta Radiol; 2011 Jun; 52(5):554-6. PubMed ID: 21498275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enchondroma: a benign osseous lesion with high F-18 FDG uptake.
    Döbert N; Menzel C; Ludwig R; Berner U; Diehl M; Hamscho N; Grünwald F
    Clin Nucl Med; 2002 Oct; 27(10):695-7. PubMed ID: 12352108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-time point
    Parghane RV; Basu S
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can 18F-FDG PET/CT alone or combined with radiology be used to reliably grade cartilage bone neoplasms for surgical decision making?
    Gundavda MK; Agarwal MG; Singh N; Gupta R; Reddy R; Bary A
    Nucl Med Commun; 2022 Feb; 43(2):220-231. PubMed ID: 34678831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
    Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT.
    Shao D; Gao Q; Tian XW; Wang SY; Liang CH; Wang SX
    Eur J Radiol; 2017 Aug; 93():114-120. PubMed ID: 28668404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
    Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF
    Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
    Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periosteal chondroid tumors: radiologic evaluation with pathologic correlation.
    Robinson P; White LM; Sundaram M; Kandel R; Wunder J; McDonald DJ; Janney C; Bell RS
    AJR Am J Roentgenol; 2001 Nov; 177(5):1183-8. PubMed ID: 11641198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients With Suspected Recurrence of Chondrosarcoma.
    Vadi SK; Mittal BR; Gorla AKR; Sood A; Basher RK; Sood A; Kakkar N; Sen RK
    Clin Nucl Med; 2018 Feb; 43(2):87-93. PubMed ID: 29261626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones.
    Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group
    J Bone Joint Surg Am; 2007 Oct; 89(10):2113-23. PubMed ID: 17908885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enchondroma and chondrosarcoma of bone: clinical, radiologic, and histologic differentiation.
    Weiner SD
    Instr Course Lect; 2004; 53():645-9. PubMed ID: 15116654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.